[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates].
作者信息
Hasegawa M, Saika T, Matsuzaki K, Kobayashi I, Fujioka T, Nasu M, Saionji K, Igari J
机构信息
Chemotherapy Division, Mitsubishi Kagaku Bio Clinical Laboratories.
出版信息
Kansenshogaku Zasshi. 1998 Mar;72(3):207-10. doi: 10.11150/kansenshogakuzasshi1970.72.207.
Abstract
Agar dilution and semi-solid agar dilution were used to determine the MIC of faropenem (FRPM) against 24 H. pylori isolates. FRPM was active against clarithromycin resistance H. pylori isolates. And, the MICs obtained by both methods were in agreement. The results suggest that FRPM was not affected by pH and is a clinically useful oral antibiotic for the eradication therapy of H. pylori infections.
摘要
Zotero 插件